Lupin Executive Says Indian Firm Seeks U.S. Buys Up To $500 Million
This article was originally published in PharmAsia News
Executive Summary
Lupin is looking for acquisitions in the U.S., both for drug makers and for brands to buy, says Vineeta Gupta, the Indian company’s group president.